Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Corn silk extract helps reduce prostate enlargement symptoms.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Finasteride works better for hair loss in patients 26 or younger.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Dutasteride reduces DHT more effectively than finasteride.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Hair loss gene linked to prostate issues.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Dutasteride works better than finasteride for preventing and treating prostate cancer.